Trials / Terminated
TerminatedNCT01311271
Effects of the Quantity of Repetitive Transcranial Magnetic Stimulation(rTMS) on the Recovery After Stroke
Effects of the Quantity of Repetitive Transcranial Magnetic Stimulation on the Recovery of Upper Motor Function After Stroke: a Randomized Controlled Trial
- Status
- Terminated
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 2 (actual)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this multicentric double blind study (randomized study) is to demonstrate the relationship between the amount of rTMS and the efficacy in the treatment of upper extremity motor deficits of stroke patients.
Detailed description
Repetitive transcranial magnetic stimulation (rTMS) can modulate excitability of the brain via non-invasive methods. In that sense, rTMS has been used to treat a variety of symptoms of stroke during last two decades. Especially, improvement of upper extremity function has been proved by many studies. However, it remains uncertain about the optimum amount of rTMS. The aim of this multicentric double blind study (randomized study) is to demonstrate the relationship between the amount of rTMS and the efficacy in the treatment of upper extremity motor deficits of stroke patients. Fifty-seven patients will be included with written consent. After randomization, the subject will receive 3 different amount of treatment rTMS-rTMS, Sham-rTMS, Sham-Sham) in double blind methods.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | repetitive transcranial magnetic stimulation (rTMS) | 1 Hz frequency, 15 minutes, intensity of 90% resting motor threshold, with one session a day, * Real: unaffected M1 hotspot * Sham: coil perpendicular to scalp |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-02-01
- First posted
- 2011-03-09
- Last updated
- 2015-05-19
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01311271. Inclusion in this directory is not an endorsement.